On the other hand, Singh (2021) found that VPA inhibited GSK3β-mediated cleavage of APP, lessened Aβ production, decreased neuritic plaque formation, and improved the memory deficits in AD transgenic mice (D. Singh et al. 2021). The gene discussed is APP; the disease is Alzheimer disease.